Insulet PE Ratio 2010-2023 | PODD
Current and historical p/e ratio for Insulet (PODD) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Insulet PE ratio as of May 15, 2024 is 53.50.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Insulet PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-05-15 | 180.56 | 62.05 | |
2023-12-31 | 216.98 | $2.91 | 74.56 |
2023-09-30 | 159.49 | $1.71 | 93.27 |
2023-06-30 | 288.34 | $0.89 | 323.98 |
2023-03-31 | 318.96 | $0.00 | 0.00 |
2022-12-31 | 294.39 | $0.06 | 4906.50 |
2022-09-30 | 229.40 | $0.24 | 955.83 |
2022-06-30 | 217.94 | $0.50 | 435.88 |
2022-03-31 | 266.39 | $0.63 | 422.84 |
2021-12-31 | 266.07 | $0.23 | 1156.83 |
2021-09-30 | 284.23 | $-0.45 | 0.00 |
2021-06-30 | 274.51 | $-0.46 | 0.00 |
2021-03-31 | 260.92 | $0.13 | 2007.08 |
2020-12-31 | 255.63 | $0.10 | 2556.30 |
2020-09-30 | 236.59 | $0.44 | 537.70 |
2020-06-30 | 194.26 | $0.28 | 693.79 |
2020-03-31 | 165.68 | $0.08 | 2071.00 |
2019-12-31 | 171.20 | $0.18 | 951.11 |
2019-09-30 | 164.93 | $0.26 | 634.35 |
2019-06-30 | 119.38 | $0.28 | 426.36 |
2019-03-31 | 95.09 | $0.23 | 413.43 |
2018-12-31 | 79.32 | $0.05 | 1586.40 |
2018-09-30 | 105.95 | $-0.23 | 0.00 |
2018-06-30 | 85.70 | $-0.30 | 0.00 |
2018-03-31 | 86.68 | $-0.40 | 0.00 |
2017-12-31 | 69.00 | $-0.46 | 0.00 |
2017-09-30 | 55.08 | $-0.50 | 0.00 |
2017-06-30 | 51.31 | $-0.51 | 0.00 |
2017-03-31 | 43.09 | $-0.46 | 0.00 |
2016-12-31 | 37.68 | $-0.51 | 0.00 |
2016-09-30 | 40.94 | $-0.83 | 0.00 |
2016-06-30 | 30.24 | $-1.11 | 0.00 |
2016-03-31 | 33.16 | $-1.30 | 0.00 |
2015-12-31 | 37.81 | $-1.29 | 0.00 |
2015-09-30 | 25.91 | $-0.91 | 0.00 |
2015-06-30 | 30.99 | $-0.77 | 0.00 |
2015-03-31 | 33.35 | $-1.03 | 0.00 |
2014-12-31 | 46.06 | $-0.93 | 0.00 |
2014-09-30 | 36.85 | $-0.87 | 0.00 |
2014-06-30 | 39.67 | $-1.07 | 0.00 |
2014-03-31 | 47.42 | $-0.74 | 0.00 |
2013-12-31 | 37.10 | $-0.83 | 0.00 |
2013-09-30 | 36.24 | $-1.00 | 0.00 |
2013-06-30 | 31.41 | $-0.87 | 0.00 |
2013-03-31 | 25.86 | $-0.97 | 0.00 |
2012-12-31 | 21.22 | $-1.08 | 0.00 |
2012-09-30 | 21.58 | $-1.17 | 0.00 |
2012-06-30 | 21.37 | $-1.20 | 0.00 |
2012-03-31 | 19.14 | $-1.32 | 0.00 |
2011-12-31 | 18.83 | $-1.23 | 0.00 |
2011-09-30 | 15.26 | $-1.43 | 0.00 |
2011-06-30 | 22.17 | $-1.44 | 0.00 |
2011-03-31 | 20.62 | $-1.38 | 0.00 |
2010-12-31 | 15.50 | $-1.58 | 0.00 |
2010-09-30 | 14.14 | $-1.96 | 0.00 |
2010-06-30 | 15.05 | $-2.39 | 0.00 |
2009-12-31 | 14.28 | $-2.74 | 0.00 |
2009-09-30 | 11.23 | $-2.69 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $12.066B | $1.697B |
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $180.939B | 23.69 |
Stryker (SYK) | United States | $123.542B | 29.59 |
Medtronic (MDT) | Ireland | $111.935B | 15.85 |
Boston Scientific (BSX) | United States | $107.817B | 34.34 |
EssilorLuxottica (ESLOY) | France | $101.153B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.922B | 0.00 |
Haleon (HLN) | United Kingdom | $37.990B | 27.73 |
ResMed (RMD) | United States | $31.710B | 29.77 |
Terumo (TRUMY) | Japan | $25.565B | 36.10 |
Koninklijke Philips (PHG) | Netherlands | $25.036B | 19.40 |
Zimmer Biomet Holdings (ZBH) | United States | $24.681B | 15.77 |
Baxter (BAX) | United States | $17.958B | 12.77 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.266B | 0.00 |
Demant (WILYY) | Denmark | $10.234B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.385B | 27.43 |
BellRing Brands (BRBR) | United States | $7.844B | 36.74 |
Lantheus Holdings (LNTH) | United States | $5.455B | 13.59 |
Haemonetics (HAE) | United States | $4.945B | 24.47 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Perrigo (PRGO) | Ireland | $4.129B | 12.52 |
Prestige Consumer Healthcare (PBH) | United States | $3.548B | 16.98 |
Envista Holdings (NVST) | United States | $3.295B | 13.60 |
QuidelOrtho (QDEL) | United States | $2.959B | 16.42 |
Neogen (NEOG) | United States | $2.835B | 27.27 |
TG Therapeutics (TGTX) | United States | $2.776B | 78.09 |
Green Thumb Industries (GTBIF) | United States | $2.714B | 53.75 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.690B | 0.00 |
ICU Medical (ICUI) | United States | $2.565B | 22.63 |
Agios Pharmaceuticals (AGIO) | United States | $1.938B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.927B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.752B | 51.34 |
InMode (INMD) | Israel | $1.560B | 8.29 |
Warby Parker (WRBY) | United States | $1.543B | 0.00 |
Owens & Minor (OMI) | United States | $1.513B | 13.19 |
AdaptHealth (AHCO) | United States | $1.306B | 9.73 |
National Vision Holdings (EYE) | United States | $1.200B | 38.20 |
AtriCure (ATRC) | United States | $1.042B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.032B | 0.00 |
Canopy Growth (CGC) | Canada | $0.983B | 0.00 |
Evolus (EOLS) | United States | $0.799B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.738B | 15.70 |
Cresco Labs (CRLBF) | United States | $0.698B | 0.00 |
Quanterix (QTRX) | United States | $0.644B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.631B | 14.83 |
PetIQ (PETQ) | United States | $0.576B | 18.82 |
Valneva SE (VALN) | France | $0.558B | 0.00 |
Jin Medical (ZJYL) | China | $0.522B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.519B | 0.00 |
Surmodics (SRDX) | United States | $0.471B | 29.46 |
ZimVie (ZIMV) | United States | $0.455B | 38.79 |
Biote (BTMD) | United States | $0.443B | 8.50 |
OraSure Technologies (OSUR) | United States | $0.403B | 12.98 |
Aurora Cannabis (ACB) | Canada | $0.382B | 0.00 |
Cerus (CERS) | United States | $0.377B | 0.00 |
Zynex (ZYXI) | United States | $0.345B | 47.22 |
MacroGenics (MGNX) | United States | $0.279B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.272B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.260B | 25.77 |
Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
Omeros (OMER) | United States | $0.243B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.242B | 15.22 |
Veru (VERU) | United States | $0.215B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.197B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.190B | 0.00 |
High Tide (HITI) | Canada | $0.182B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.164B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.152B | 73.06 |
InterCure (INCR) | Israel | $0.148B | 24.96 |
FitLife Brands (FTLF) | United States | $0.136B | 19.36 |
Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.114B | 0.00 |
Fonar (FONR) | United States | $0.104B | 8.94 |
Allurion Technologies (ALUR) | United States | $0.101B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
MariMed (MRMD) | United States | $0.096B | 0.00 |
Brainsway (BWAY) | Israel | $0.091B | 0.00 |
Chimerix (CMRX) | United States | $0.090B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
Safety Shot (SHOT) | United States | $0.067B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.96 |
Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
ImmuCell (ICCC) | United States | $0.043B | 0.00 |
United-Guardian (UG) | United States | $0.042B | 15.08 |
Bright Green (BGXX) | United States | $0.041B | 0.00 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
Exagen (XGN) | United States | $0.031B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Flora Growth (FLGC) | United States | $0.016B | 0.00 |
GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.003B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |